SEC Form 4 · accession 0001179110-16-027939
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Warmuth
Officer — Executive Vice President
Period of report
Jul 26, 2016
Accepted (ET)
Jul 27, 2016 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Jul 26, 2016 | M | 26,800 | $25.2461 | A | 81,811 | D | |
| Common shares without par value | Jul 26, 2016 | S | 11,951 | $43.48 | D | 69,860 | D | |
| Common shares without par value | Jul 26, 2016 | S | 10,349 | $43.49 | D | 59,511 | D | |
| Common shares without par value | Jul 26, 2016 | S | 4,500 | $43.50 | D | 55,011 | D | |
| Common shares without par valueF1 | holding | — | — | — | 29,586 | I | By trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F2 | $25.2461 | Jul 26, 2016 | M | 26,800 | D | Feb 16, 2010 | Feb 15, 2017 | Common shares | 26,800 | 0 | D |
Explanation of responses
- F1Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.
- F2Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).